Table-1.
Autoimmune conditions |
Authors | Finding | Reference number |
---|---|---|---|
Rheumatoid arthritis | Rathi, B., et al. | Oral polyphenolic fraction of Ceylon cinnamon protected arthritis in a rat model. | 16 |
Rheumatoid arthritis | Cheng, W., X. et al. | Oral cinnamaldehyde protected rats from collagen-induced arthritic rats. | 17 |
Rheumatoid arthritis | Shishehbor, F., et al. | Oral cinnamon reduced disease severity in women with rheumatoid arthritis | 18 |
Type 1 diabetes | Shen, Y., et al. | Ceylon cinnamon exhibited anti-diabetic effect in insulin-uncontrolled type 1 diabetic rats | 24 |
Type 1 diabetes | Altschuler, J. A., et al. | Oral cinnamon did not show significant anti-diabetic effect in adolescent TIDM patients. | 25 |
Type 1 diabetes | Baker, W. L., et al. | Upon meta-analysis of prospective randomized controlled trials, cinnamon did not display anti-diabetic effect. | 26 |
Multiple sclerosis | Brahmachari, S., et al. | Sodium benzoate, a metabolite of cinnamon, exhibited protection in a mouse model of MS. | 14 |
Multiple sclerosis | Mondal, S., et al. | Oral cinnamon displayed protection in three different animal models of MS. | 12 |
Inflammatory bowel disease | Kwon, H.K., et al. | Oral cinnamon extract protected mice from intestinal colitis. | 38 |
Inflammatory bowel disease | Hagenlocher, Y., et al. | Cinnamaldehyde decreased fibrotic symptoms and markers in a mouse model of colitis. | 39 |
Inflammatory bowel disease | Hagenlocher, Y., et al. | Oral cinnamon extract reduces murine colitis in IL-10−/− mice. | 40 |
Inflammatory bowel disease | Li, A.L., et al. | Cinnamon essential oil protected mice from dextran sodium sulfate-induced colitis. | 41 |